Select Website
US Website
Hi, Sign in
My Market
Submit a Request for Quote
Cart
My Quote
Toggle Nav
Menu
Categories
Account
  • Home
  • Search results for: 'deuterium oxide 10 10 x 0.0.1 ml 99.8 d'

Search results for: 'deuterium oxide 10 10 x 0.0.1 ml 99.8 d'

View as List Grid
Set Ascending Direction
per page

76 Items

  1. CCND10073P10

    13C, 15N, D fMLF

    CCND10073P10
    3 - 6 weeks
    • 10 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  2. CCND10063P10

    13C, 15N, D Microcrystalline Ubiquitin

    CCND10063P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  3. 13C, 15N, D Microcrystalline SH3

    13C, 15N, D Microcrystalline SH3

    CCND10053P10
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  4. CCND10064P10

    13C, 15N, D Ubiquitin in Solution

    CCND10064P10
    3 - 6 weeks
    • 10 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  5. CCDN4002P001

    L-Alanine-β-13C,α-D,15N

    CCDN4002P001
    2 - 4 weeks
    10 mg
  6. 13C, 15N, D SH3 in Solution

    13C, 15N, D SH3 in Solution

    CCND10054P10
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  7. CCND10033P10

    13C, 15N, D Microcrystalline GB1

    CCND10033P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N, D
  8. CCND10044P10

    13C, 15N, D MBP in Solution

    CCND10044P10
    3 - 6 weeks
    • 10 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N, D
  9. CCND10034P10

    13C, 15N, D GB1 in Solution

    CCND10034P10
    3 - 6 weeks
    • 10 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N, D
  10. 13C, 15N, D Microcrystalline SH3

    13C, 15N, D Microcrystalline SH3

    CCND10053P20
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  11. 13C, 15N, D Microcrystalline SH3

    13C, 15N, D Microcrystalline SH3

    CCND10053P5
    3 - 6 weeks
    • 10 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  12. CCDN4014P001

    L-Isoleucine-δ-13CH3,D7,15N

    CCDN4014P001
    2 - 4 weeks
    10 mg
  13. CCND100613P

    13C, 15N, D Ubiquitin in 3 mm NMR Tube

    CCND100613P
    3 - 6 weeks
    • Full Length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
    • Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H2O/D2O: 90/10
  14. CCND100615P

    13C, 15N, D Ubiquitin in 5 mm NMR Tube

    CCND100615P
    3 - 6 weeks
    • Full Length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
    • Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H2O/D2O: 90/10
  15. CCND071P1

    Cell-Free Amino Acid mixture - 13C, 15N, D

    CCND071P1
    stock
    • Mixture of 20 Amino Acids, 13C, 15N, D
    • Packaging: 1 mL
  16. CCDN4013P001

    L-Isoleucine-γ2,δ-(13CH3)2,D4,15N

    CCDN4013P001
    2 - 4 weeks
    10 mg
  17. CCND10073P20

    13C, 15N, D fMLF

    CCND10073P20
    3 - 6 weeks
    • 20 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  18. CCND10073P5

    13C, 15N, D fMLF

    CCND10073P5
    3 - 6 weeks
    • 5 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  19. CCND10073P50

    13C, 15N, D fMLF

    CCND10073P50
    3 - 6 weeks
    • 50 mg
    • N-formyl-methionyl-leucyl-phenylalanine (fMLF)
    • Labeling: 13C, 15N, D
    • Crystallized
  20. CCND100115P

    13C, 15N, D Calbindin in 5 mm NMR Tube

    CCND100115P
    3 - 6 weeks
    • Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
    • Calcium loaded (Ca and Ln loaded also available on request)
    • Protein size: 8.5 kDa
    • Labeling: 13C, 15N, D
    • Concentration: 1 mM
    • H2O/D2O: 90/10, pH: 6.0
    • Protein supplied in a 3 mm NMR tube sealed under Argon
  21. CCND10063P20

    13C, 15N, D Microcrystalline Ubiquitin

    CCND10063P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  22. CCND10063P5

    13C, 15N, D Microcrystalline Ubiquitin

    CCND10063P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  23. CCDN4015P001

    L-Isoleucine-γ-13CH3,D7,15N

    CCDN4015P001
    2 - 4 weeks
    10 mg
  24. CCDN4018P001

    L-Leucine-δ2-13CH3,D7,15N

    CCDN4018P001
    2 - 4 weeks
    10 mg
  25. CCDN4019P001

    L-Leucine-δ1-13CH3,D7,15N

    CCDN4019P001
    2 - 4 weeks
    10 mg
  26. CCDN4025P001

    L-Methionine-ε-13CH3,D5,15N

    CCDN4025P001
    2 - 4 weeks
    10 mg
  27. CCDN4028P001

    L-Phenylalanine-ζ-13CH,D7,15N

    CCDN4028P001
    2 - 4 weeks
    10 mg
  28. CCDN4030P001

    L-Phenylalanine-ε-13CH,D6,15N

    CCDN4030P001
    2 - 4 weeks
    10 mg
  29. CCDN4037P001

    L-Tyrosine-ε-13CH,D5,15N

    CCDN4037P001
    2 - 4 weeks
    10 mg
  30. CCDN4041P001

    L-Valine-γ1-13CH3,D5,15N

    CCDN4041P001
    2 - 4 weeks
    10 mg
  31. CCDN4042P001

    L-Valine-γ2-13CH3,D5,15N

    CCDN4042P001
    2 - 4 weeks
    10 mg
  32. CCND10033P20

    13C, 15N, D Microcrystalline GB1

    CCND10033P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N, D
  33. CCND10033P5

    13C, 15N, D Microcrystalline GB1

    CCND10033P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N, D
  34. CCND10064P20

    13C, 15N, D Ubiquitin in Solution

    CCND10064P20
    3 - 6 weeks
    • 20 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  35. CCND10064P5

    13C, 15N, D Ubiquitin in Solution

    CCND10064P5
    3 - 6 weeks
    • 5 mg
    • Full length Ubiquitin (Residue 1-76)
    • Protein size: 6.8 kDa
    • Labeling: 13C, 15N, D
  36. 13C, 15N, D SH3 in Solution

    13C, 15N, D SH3 in Solution

    CCND10054P20
    3 - 6 weeks
    • 20 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  37. 13C, 15N, D SH3 in Solution

    13C, 15N, D SH3 in Solution

    CCND10054P5
    3 - 6 weeks
    • 5 mg
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 k Da
    • Labeling: 13C, 15N, D
  38. CCND10044P20

    13C, 15N, D MBP in Solution

    CCND10044P20
    3 - 6 weeks
    • 20 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N, D
  39. CCND10044P5

    13C, 15N, D MBP in Solution

    CCND10044P5
    3 - 6 weeks
    • 5 mg
    • Maltose Binding Protein (Recombinant MBP)
    • Recombinant MBP
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Labeling: 13C, 15N, D
  40. CCND10034P20

    13C, 15N, D GB1 in Solution

    CCND10034P20
    3 - 6 weeks
    • 20 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N, D
  41. CCND10034P5

    13C, 15N, D GB1 in Solution

    CCND10034P5
    3 - 6 weeks
    • 5 mg
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • 6.2 kDa
    • Labeling: 13C, 15N, D
  42. CCDN540P1

    Isogro-13C,15N,D

    CCDN540P1
    $620.00
    2 - 4 weeks
    • 1 g
    • 13C, 15N, D labeled
    • Powder Growth Media
  43. CCDN4009P

    Glycine-13C2,α3-D,15N

    CCDN4009P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  44. 13C, 15N, D SH3 in 1.3mm Bruker rotor

    13C, 15N, D SH3 in 1.3mm Bruker rotor

    CCND100521P
    3 - 6 weeks
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  45. 13C, 15N, D SH3 in 3.2mm Bruker rotor

    13C, 15N, D SH3 in 3.2mm Bruker rotor

    CCND100523P
    3 - 6 weeks
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
  46. CCDN4004P

    L-Asparagine-13C4,β3-D,15N2

    CCDN4004P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  47. CCDN4006P

    L-Cysteine-13C3,β3-D,15N

    CCDN4006P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  48. CCDN4010P

    L-Histidine-13C6,β3-D,15N3

    CCDN4010P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  49. CCDN4032P

    L-Serine-13C3,β2-D,15N

    CCDN4032P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  50. CCDN070P1

    Algal Amino Acids Mixture-13C, 15N, D (16 Amino Acids)

    CCDN070P1
    $2,090.00
    2 - 4 weeks
    • 1 g
    • 98% 13C, 98% 15N, 98% D
    • Deficient in glutamine, asparagine, cysteine, and tryptophan.
  51. 13C, 15N, D SH3 in 3mm NMR Tube

    13C, 15N, D SH3 in 3mm NMR Tube

    CCND100513P
    3 - 6 weeks
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
    • Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
    • Stable for more than 2 years at 4°C
  52. 13C, 15N, D SH3 in 5mm NMR Tube

    13C, 15N, D SH3 in 5mm NMR Tube

    CCND100515P
    3 - 6 weeks
    • SRC Homology 3 domain (SH3)
    • Number of residues: 62
    • Protein size: 5.6 kDa
    • Labeling: 13C, 15N, D
    • Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
    • Stable for more than 2 years at 4°C
  53. CCND100323P

    13C, 15N, D GB1 in 3.2 mm Bruker rotor

    CCND100323P
    3 - 6 weeks
    • B-1 Immunoglobulin G Binding Domain (GB1)
    • Residues 303-357 of the protein G, with T303Q mutation
    • Size: 6.2 kDa
    • Labeling: 13C, 15N, D
  54. CCDN4001P

    L-Alanine-β-13CHD2,α-D,15N

    CCDN4001P
    2 - 4 weeks
  55. CCDN4005P

    L-Aspartic Acid-13C4,β2-D,15N

    CCDN4005P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  56. CCND100413P

    13C, 15N, D MBP in 3 mm NMR Tube

    CCND100413P
    3 - 6 weeks
    • Maltose Binding Protein (Recombinant MBP)
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Protein conc.: 1 mM
    • Labeling: 13C, 15N, D
    • 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN3: 3 mM, Pefabloc: 50 µM
  57. CCND100415P

    13C, 15N, D MBP in 5 mm NMR Tube

    CCND100415P
    3 - 6 weeks
    • Maltose Binding Protein (Recombinant MBP)
    • Size: 40.3 kDa
    • Residues: 27-392 with T28I mutation
    • Protein conc.: 1 mM
    • Labeling: 13C, 15N, D
    • 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN3: 3 mM, Pefabloc: 50 µM
  58. CCDN3780L

    Spectra 9-DCN

    CCDN3780L
    2 - 4 weeks
    98%13C, 98%15N, 98% D
  59. CCDN1200P

    L-Histidine-13C6, 15N3, α,β,β,2,5-d5

    CCDN1200P01
    2 - 4 weeks
    • 100 mg• 99% 13C, 98% D, 98% 15N
    • 95% CP
  60. CCDN2200P

    L-Phenylalanine-13C9, 15N, α,β,β,2,3,4,5,6-d8

    CCDN2200P01
    2 - 4 weeks
    • 100 mg• 99% 13C, 98% D, 98% 15N
    • 95% CP
  61. CCDN5000P

    L-Valine-13C5,15N,2,3,4,4,4-d5-(4-methyl-d3)

    CCDN5000P01
    2 - 4 weeks
    • 100 mg• 99% 13C, 98% D, 98% 15N
    • 95% CP
  62. CCCDN500P

    L-Cysteine-13C3,15N,2,3,3-d3

    CCDN500P01
    2 - 4 weeks
    • 100 mg• 98% 13C, 98% D, 98% 15N
    • 95% CP
  63. CCDN55P

    L-Alanine-13C3, 15N, 2,3,3,3-d4

    CCDN55P01
    2 - 4 weeks
    • 100 mg • 99% 13C, 98% D, 98% 15N
    • 95% CP
  64. CCDN530P

    Celtone-CDN

    CCDN530P
    2 - 4 weeks
    • Powder Only
    • 98% 13C, 98% 15N, 98% D
  65. CCDN531L

    Celtone-CDN

    CCDN531L
    2 - 4 weeks
    • Complete Media
    • 98% 13C, 98% 15N, 98% D
  66. CCDN4033P

    L-Threonine-13C4,δ,δ-D2,15N

    CCDN4033P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  67. CCDN4200P

    L-Tyrosine-13C9, 15N, -d7

    CCDN4200P
    2 - 4 weeks
    99% 13C, 98% 15N, 98% D
  68. CCDN900P

    L-Glutamic Acid-13C5, 15N, -d9

    CCDN900P
    2 - 4 weeks
    • 98% 13C, 98% D, 98% 15N
    • 95% CP
  69. CCDN1090

    Glycine-13C2, 15N, 2,2-d2

    CCDN1090P01
    2 - 4 weeks
    H215N13CD213CO2H
  70. CCDN1300P

    L-Isoleucine-13C6, 15N, 2,3,4,4,5,5,5-d7,3-methyl-d3

    CCDN1300P01
    2 - 4 weeks
    13CD313CD213CD(13CD3)13CD(15NH2)CO2H
  71. CCDN2000P

    L-Methionine-13C5, 15N, 2,3,3,4,4-d5-(methyl-d3)

    CCDN2000P01
    2 - 4 weeks
    13CD3S13CD213CD213CD(15NH2)13CO2H
  72. CCDN2500P

    L-Proline-13C5, 15N, 2,3,3,4,4,5,5-d7

    CCDN2500P01
    2 - 4 weeks
    13C4D715NH13CO2H
  73. CCDN3000P

    L-Serine-13C3,15N,2,3,3-d3

    CCDN3000P01
    2 - 4 weeks
    HO13CD213CD(15NH2)13CO2H
  74. CCDN4050P

    L-Tryptophan-13C11,15N2,α,β,β,2,4,5,6,7-d8

    CCDN4050P01
    2 - 4 weeks
    • 100 mg• 97% 13C
    • 98% CP
  75. CCDN4036P

    L-Tyrosine-c’,α,β,γ,ε1,ε2-13C6, β2,δ-D3,15N

    CCDN4036P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
  76. CCDN4026P

    L-Phenylalanine-c’,α,β,γ,ζ-13C5,β2,δ,ε1,ε2-D5,15N

    CCDN4026P
    2 - 4 weeks
    • Original SAIL amino acid
    • Preservation of through-bond connectivity
    • Reduction of spin diffusion
    • Removal of 2JHH couplings
    • Reduction of number of protons 50%
View as List Grid
Set Ascending Direction
per page

76 Items